Compugen Correlations

CGEN Stock

USD 1.61 0.09 5.92%

The current 90-days correlation between Compugen and Surface Oncology is 0.07 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Compugen Correlation With Market

Very weak diversification

The correlation between Compugen and DJI is 0.48 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Compugen and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

Moving together with Compugen Stock

0.88	VALN	Valneva SE ADR	Pair Corr
0.64	VRAX	Virax Biolabs Group	Pair Corr
0.87	ERNA	Eterna Therapeutics	Pair Corr
0.8	FDMT	4D Molecular Therapeutics	Pair Corr
0.88	ICU	LMF Acquisition Oppo	Pair Corr
0.88	IQV	IQVIA Holdings	Pair Corr
0.77	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.8	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.84	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.72	MTD	Mettler Toledo Inter	Pair Corr
0.72	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.69	SHC	Sotera Health	Pair Corr
0.79	ICLR	ICON PLC	Pair Corr
0.82	ZVSA	ZyVersa Therapeutics	Pair Corr
0.64	INKT	Mink Therapeutics	Pair Corr
0.78	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.67	BIAFW	BioAffinity Technologies	Pair Corr

Moving against Compugen Stock

0.84	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.77	ESPR	Esperion Therapeutics	Pair Corr
0.69	GILD	Gilead Sciences	Pair Corr
0.66	DRUG	Bright Minds Biosciences	Pair Corr
0.62	NBY	NovaBay Pharmaceuticals	Pair Corr
0.38	FLGC	Flora Growth Corp	Pair Corr
0.68	NAMS	NewAmsterdam Pharma	Pair Corr
0.59	LPCN	Lipocine	Pair Corr
0.48	ESLAW	Estrella Immunopharma	Pair Corr
0.4	KMDA	Kamada	Pair Corr
0.37	MNOV	MediciNova	Pair Corr

Related Correlations Analysis

	PHGE	PLUR	SURF	BLRX	ITOS	ICVX	MRTX	VECT	ANNX	ALLO
PHGE		0.4	-0.84	0.8	0.77	-0.66	0.74	-0.82	0.06	0.31	PHGE
PLUR	0.4		-0.27	0.56	0.39	-0.43	0.5	-0.62	-0.54	-0.05	PLUR
SURF	-0.84	-0.27		-0.79	-0.78	0.71	-0.78	0.82	-0.01	-0.19	SURF
BLRX	0.8	0.56	-0.79		0.76	-0.73	0.85	-0.84	-0.16	0.18	BLRX
ITOS	0.77	0.39	-0.78	0.76		-0.91	0.62	-0.8	-0.27	0.13	ITOS
ICVX	-0.66	-0.43	0.71	-0.73	-0.91		-0.59	0.76	0.41	-0.01	ICVX
MRTX	0.74	0.5	-0.78	0.85	0.62	-0.59		-0.75	0.04	0.37	MRTX
VECT	-0.82	-0.62	0.82	-0.84	-0.8	0.76	-0.75		0.38	-0.06	VECT
ANNX	0.06	-0.54	-0.01	-0.16	-0.27	0.41	0.04	0.38		0.63	ANNX
ALLO	0.31	-0.05	-0.19	0.18	0.13	-0.01	0.37	-0.06	0.63		ALLO
	PHGE	PLUR	SURF	BLRX	ITOS	ICVX	MRTX	VECT	ANNX	ALLO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MRTX	+ 0.85	BLRX
VECT	+ 0.82	SURF
BLRX	+ 0.8	PHGE
ITOS	+ 0.77	PHGE
ITOS	+ 0.76	BLRX
VECT	+ 0.76	ICVX

High negative correlations

ICVX	- 0.91	ITOS
VECT	- 0.84	BLRX
SURF	- 0.84	PHGE
VECT	- 0.82	PHGE
VECT	- 0.8	ITOS
BLRX	- 0.79	SURF

Risk-Adjusted Indicators

There is a big difference between Compugen Stock performing well and Compugen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Compugen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PHGE	3.81	(1.35)	0.00	(1.07)	0.00	0.00	5.56	(8.33)	29.33
PLUR	3.96	0.07	0.00	0.22	4.67	(4.37)	8.53	(8.45)	21.61
SURF	3.20	0.62	0.13	9.58	3.13	(4.16)	8.51	(5.05)	24.63
BLRX	3.96	(1.10)	0.00	3.13	0.00	0.00	4.88	(9.80)	59.21
ITOS	2.61	(1.26)	0.00	(0.78)	0.00	0.00	4.26	(4.52)	33.24
ICVX	4.87	1.33	0.17	(0.37)	4.56	(5.67)	10.22	(6.79)	38.57
MRTX	2.24	(0.50)	0.00	(0.73)	0.00	0.00	4.02	(4.07)	16.13
VECT	2.63	1.08	0.54	3.70	0.88	(3.64)	5.61	(3.08)	39.30
ANNX	2.57	(0.38)	0.00	(0.09)	0.00	0.00	6.98	(5.26)	23.00
ALLO	4.31	(0.34)	0.00	(0.01)	0.00	0.00	10.29	(8.09)	23.67

Compugen Corporate Management

Zurit Levine	VP of Research and Discovery	Profile
Alberto Sessa	Chief Officer	Profile
Rivka Schwartz	Vice Discovery	Profile
Henry MD	Senior Officer	Profile
Eran Ophir	Chief Officer	Profile
Michelle MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC